{"title":"老年组多发性骨髓瘤患者自体干细胞移植的成功和毒性评价","authors":"M. Ucar, S. Dagdas, F. Ceran, M. Falay, G. Özet","doi":"10.17352/sscrt.000012","DOIUrl":null,"url":null,"abstract":"Background: Our objective in this study is to compare the outcomes of patients with multiple myeloma \n(MM) over 65 years of age who had autologous hematopoietic stem cell transplantation (AHSCT) with the \noutcomes of patients under 65 years of age.","PeriodicalId":227339,"journal":{"name":"Studies on Stem Cells Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group\",\"authors\":\"M. Ucar, S. Dagdas, F. Ceran, M. Falay, G. Özet\",\"doi\":\"10.17352/sscrt.000012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Our objective in this study is to compare the outcomes of patients with multiple myeloma \\n(MM) over 65 years of age who had autologous hematopoietic stem cell transplantation (AHSCT) with the \\noutcomes of patients under 65 years of age.\",\"PeriodicalId\":227339,\"journal\":{\"name\":\"Studies on Stem Cells Research and Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Studies on Stem Cells Research and Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17352/sscrt.000012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Studies on Stem Cells Research and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/sscrt.000012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group
Background: Our objective in this study is to compare the outcomes of patients with multiple myeloma
(MM) over 65 years of age who had autologous hematopoietic stem cell transplantation (AHSCT) with the
outcomes of patients under 65 years of age.